Form 4: Gravitas Capital LP Acquires THAR Stock Options

Gravitas Capital LP, a 10% owner and director of Tharimmune, Inc., reported the acquisition of 90,000 stock options with an exercise price of $3.075.

Summary

• Gravitas Capital LP, identified as a 10% owner and director of Tharimmune, Inc. (THAR), filed a Form 4.
• The filing reports the acquisition of 90,000 derivative securities in the form of stock options.
• These options have an exercise price of $3.075 per share.
• The transaction date for the acquisition was November 3, 2025.
• The options become exercisable on November 3, 2025, and expire on November 3, 2035.
• Each option represents the right to acquire one share of Tharimmune, Inc. Common Stock.
• Following this transaction, Gravitas Capital LP beneficially owns 190,000 derivative securities indirectly.
• Vincent S. LoPriore, managing member of Gravitas Capital Partners LLC (the sole general partner of Gravitas Capital LP), is deemed an indirect owner of these securities.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a 10% owner and director is generally viewed as a positive signal, indicating insider confidence in the company's future performance and potential for stock price appreciation.

Positives

• A 10% owner and director acquiring additional stock options signals confidence in the company's future prospects and potential upside.
• The acquisition of 90,000 options increases the insider's stake, aligning their interests further with those of other shareholders.

Industry Context

This filing is a routine disclosure of an insider transaction and does not provide broader industry context or trends. It reflects a specific investment decision by a significant stakeholder in Tharimmune, Inc.

Related Party Transactions

• Gravitas Capital LP is a Delaware limited partnership whose sole general partner is Gravitas Capital Partners LLC. Vincent S. LoPriore is the managing member of Gravitas Partners LLC.
• Gravitas Capital LP is deemed to be the indirect owner of securities held directly by Vincent S. LoPriore.
• The reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, despite shared beneficial ownership.

Stakeholder Impact

• Shareholders may interpret this insider option acquisition as a positive indicator of management's belief in the company's future value, potentially boosting investor confidence.
• The increased alignment of interests between a significant owner/director and other shareholders could be seen favorably.

Key Dates

Recommendation

The acquisition of a substantial number of stock options by a 10% owner and director, Gravitas Capital LP, signals strong insider confidence in Tharimmune, Inc.'s future prospects. This type of insider buying, especially by a significant stakeholder, often precedes positive company developments or reflects an expectation of future stock price appreciation, making it a compelling 'buy' signal for investors.

Keywords

Tharimmune, THAR, Gravitas Capital LP, Stock Options, Insider Transaction, Beneficial Ownership, Form 4, Derivative Securities